Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by CytoSorbents
CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
August 13, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
August 13, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
AXGN
CTSO
CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
August 07, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
ALT
CTSO
CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
August 01, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
July 29, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
July 17, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
June 13, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Secures $20 Million Credit Facility
July 02, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
June 05, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
June 24, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
June 04, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Reports First Quarter 2024 Results
May 09, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe
May 02, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents to Report First Quarter 2024 Operating and Financial Results
April 26, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
April 17, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
March 06, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
February 08, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
January 17, 2024
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
December 28, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering
December 13, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results
November 09, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents to Report Third Quarter 2023 Operating and Financial Results
October 27, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents to Present at the 8th Annual Dawson James Conference
October 05, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry
September 27, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
September 19, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
September 11, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
September 01, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
August 31, 2023
From
CytoSorbents
Via
GlobeNewswire
Tickers
CTSO
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.